GOLDN
LIVE

Serial Number

98265102

Owner

Novodx Corporation

Attorney

Nikki Siesel

Filing Date

Nov 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

GOLDN Trademark

Serial Number: 98265102

GOLDN is a trademark filed by Novodx Corporation on November 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Novodx Corporation

177 US Highway 1 #309
Tequesta, FL 33469

Entity Type: 03

Trademark Details

Filing Date

November 10, 2023

Registration Date

Not Registered

Published for Opposition

August 13, 2024

Goods & Services

handheld reusable meter that tests for respiratory disease, namely, COVID-19, flu, RSV, strept A, tuberculosis, cholera, legionella, adenoviruses, and clostridium difficile infection; handheld reusable meter that test for malaria, Ebola, Marburg, typhoid, levels of vitamin D, thyroid disease, levels of cortisol, breast cancer, pancreatic cancer, bladder cancer, colorectal cancer, levels of hormones, sexually transmitted disease, cardiovascular disease, the presence of tricyclic antidepressant drugs, the presence of propoxyphene, inflammation markers, thyroid markers, Norovirus, salmonella, giardia, cryptosprodium, and entamoeba; Handheld reusable meter and test cassettes sold as a unit that tests for respiratory disease, namely, COVID-19, flu, RSV, strept A, tuberculosis, cholera, legionella, adenoviruses, and clostridium difficile infection; Handheld reusable meter and test cassettes sold as a unit that tests for malaria, Ebola, Marburg, typhoid, levels of vitamin D, thyroid disease, levels of cortisol, breast cancer, pancreatic cancer, bladder cancer, colorectal cancer, levels of hormones, sexually transmitted disease, cardiovascular disease, the presence of tricyclic antidepressant drugs, the presence of propoxyphene, inflammation markers, thyroid markers, Norovirus, salmonella, giardia, cryptosprodium, and entamoeba

diagnostic medical cassettes composed of reagents that test for respiratory disease, namely, COVID-19, flu, RSV, strept A, tuberculosis, cholera, legionella, adenoviruses, and clostridium difficile infection; diagnostic medical cassettes composed of reagents that test for malaria, Ebola, Marburg, typhoid, levels of vitamin D, thyroid disease, levels of cortisol, breast cancer, pancreatic cancer, bladder cancer, colorectal cancer, levels of hormones, sexually transmitted disease, cardiovascular disease, the presence of tricyclic antidepressant drugs, the presence of propoxyphene, inflammation markers, thyroid markers, Norovirus, salmonella, giardia, cryptosprodium, and entamoeba

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 3, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 3, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 3, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 2, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 2, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 2, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 3, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 3, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 3, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 24, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 14, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2023 NWOS
NEW APPLICATION ENTERED
Nov 14, 2023 NWAP